The global laser capture microdissection market is anticipated to reach USD 329.0 million by 2030, growing at a CAGR of 8.37% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for precise and detailed cellular analysis across various research and clinical applications. The growing focus on personalized medicine, advancements in genomics and proteomics, and rising investments in cancer research are key factors fueling the market growth over the forecast period.
The COVID-19 pandemic has positively impacted the laser capture microdissection (LCM) market. The pandemic accelerated the adoption of precision medicine and advanced diagnostics, as researchers and healthcare professionals sought more detailed and accurate analytical tools. In addition, the growing focus on the virus has led to more research into how it works and the development of new diagnostic tools, increasing the demand for advanced technologies like LCM.
Moreover, the increasing funding for cancer research is significantly driving market growth. The growing investment is anticipated to enhance research capabilities and advancing technologies, thereby leading to increased adoption of laser capture microdissection for its precision in isolating specific cells and tissues for detailed analysis. Thus, researchers are better equipped to study cancer at a molecular level, leading to innovations in diagnostics and therapeutics.
However, the high cost is a significant factor anticipated to limit the adoption of LCM systems. The initial investment for LCM equipment is substantial, which can be a barrier for smaller laboratories or research settings with limited budgets. In addition to the high purchase price of the LCM systems, the costs for consumables such as slides, reagents, and other materials needed for each procedure are further expected to hamper the growth of the market.
Request a free sample copy or view report summary: Laser Capture Microdissection Market Report
Based on type, consumables dominated with the highest revenue share of 32.66% in 2023. The segment is further divided into reagents & media, assay kits, and others. The frequent use of these consumables in various research applications, including cancer studies, genomics, and proteomics, boosts the demand and market share. On the other hand, software is anticipated to grow at the highest CAGR over the forecast period.
Based on application, the research & development held the largest revenue share in 2023 and is anticipated to grow at the fastest CAGR from 2024 to 2030. This is attributed to the extensive use of laser capture microdissection (LCM) technologies in various research fields, such as cancer research, genomics, and proteomics. However, diagnostics is projected to witness a significant growth rate over the forecast period.
Based on end use, academic & research institutes dominated the segment with the largest revenue share of 46.85% in 2023. This is attributed to the advanced studies in cancer research, genomics, and proteomics. On the other hand, pharmaceutical & biotech companies are anticipated to grow at the highest CAGR over the forecast period.
The North American region dominated the market share of 36.11% in 2023 owing to the strong pharmaceutical & biotechnology companies, advanced research institutes, substantial investment in life science R&D, and increasing focus on biologics and personalized medicine. On the other hand, Asia Pacific anticipated growing at the highest CAGR over the forecast period.
Grand View Research has segmented the global laser capture microdissection market based on type, application, end-use, and region:
Laser Capture Microdissection Type Outlook (Revenue, USD Million, 2018 - 2030)
Instruments
Ultraviolet LCM
Infrared LCM
Ultraviolet & Infrared LCM
Immunofluorescence LCM
Consumables
Reagents & Media
Assay Kits
Others
Software
Services
Laser Capture Microdissection Application Outlook (Revenue, USD Million, 2018 - 2030)
Research & Development
Molecular Biology
Cell Biology
Forensic Science
Diagnostics
Others
Laser Capture Microdissection End-use Outlook (Revenue, USD Million, 2018 - 2030)
Academic & Research Institute
Hospitals
Pharmaceutical & Biotech Companies
CRO
Laser Capture Microdissection Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Laser Capture Microdissection Market
Carl Zeiss Meditec AG
Thermo Fisher Scientific
Danaher Corporation (Leica Microsystems)
Molecular Machines & Industries GmbH
Standard BioTools Inc.
Caresbio Laboratory LLC
VitroVivo Biotech
GnomeDX
Bruker
"The quality of research they have done for us has been excellent..."